Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -230460.98% is in line with its 5-year average of -216104.54%, near the high end of its 5-year range (-1237600.00%–20994.55%).
16.78% below its 12-month average of -197349.38%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-230460.98%
OPERATING MARGIN AVG TTM
-197349.38%
OPERATING MARGIN AVG 3Y
-298746.39%
OPERATING MARGIN AVG 5Y
-216104.54%
OPERATING MARGIN AVG 10Y
-35205.19%
OPERATING MARGIN AVG 15Y
-11928.88%
OPERATING MARGIN AVG 20Y
-262.14%
CURRENT VS TTM AVG
-16.78%
CURRENT VS 3Y AVG
+22.86%
CURRENT VS 5Y AVG
-6.64%
CURRENT VS 10Y AVG
-554.62%
CURRENT VS 15Y AVG
-1831.96%
CURRENT VS 20Y AVG
-87816.39%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 551 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Altimmune, Inc.
Market Cap
$520.22M
Operating Margin
-230460.98%
TTM Avg
-197349.38%
3Y Avg
-298746.39%
5Y Avg
-216104.54%
Market Cap
$530.79M
Operating Margin
-1407.52%
TTM Avg
-703.76%
3Y Avg
-114341.22%
5Y Avg
-77223.74%
Market Cap
$512.56M
Operating Margin
0.00%
TTM Avg
-620906.82%
3Y Avg
-450471.78%
5Y Avg
-300340.85%
Market Cap
$528.02M
Operating Margin
-46.01%
TTM Avg
-85.84%
3Y Avg
-83.08%
5Y Avg
-67.71%
Market Cap
$540.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$541.64M
Operating Margin
-1.90%
TTM Avg
-16.29%
3Y Avg
-781.66%
5Y Avg
-851.82%
Market Cap
$557.41M
Operating Margin
-29.35%
TTM Avg
-5.63%
3Y Avg
-52.07%
5Y Avg
-106.16%
Market Cap
$478.28M
Operating Margin
-7.33%
TTM Avg
-12.79%
3Y Avg
-23.47%
5Y Avg
-68.20%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | $520.22M | -230460.98% | -197349.38% | -298746.39% | -216104.54% |
| Crescent Biopharma, Inc. (CBIO)vs › | $530.79M | -1407.52% | -703.76% | -114341.22% | -77223.74% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $512.56M | 0.00% | -620906.82% | -450471.78% | -300340.85% |
| 908 Devices Inc. (MASS)vs › | $528.02M | -46.01% | -85.84% | -83.08% | -67.71% |
| Immix Biopharma, Inc. (IMMX)vs › | $540.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Delcath Systems, Inc. (DCTH)vs › | $541.64M | -1.90% | -16.29% | -781.66% | -851.82% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.41M | -29.35% | -5.63% | -52.07% | -106.16% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $478.28M | -7.33% | -12.79% | -23.47% | -68.20% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $474.97M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
Operating Margin
-230461.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -111126.92% |
| 2025-09-30 | -417180.00% |
| 2025-06-30 | -458440.00% |
| 2025-03-31 | -436300.00% |
| 2024-12-31 | -497320.00% |
| 2024-09-30 | -495340.00% |
| 2024-06-30 | -534900.00% |
| 2024-03-31 | -535880.00% |
| 2023-12-31 | -90872.97% |
| 2023-09-30 | -6226.52% |
| 2023-06-30 | -300116.67% |
| 2023-03-31 | -103614.29% |
| 2022-12-31 | 20994.55% |
| 2022-09-30 | -1237600.00% |
| 2022-06-30 | -254937.50% |
| 2022-03-31 | -60934.38% |
| 2021-12-31 | -731.92% |
| 2021-09-30 | -21015.19% |
| 2021-06-30 | -18148.91% |
| 2021-03-31 | -1773.39% |
| 2020-12-31 | -464.81% |
| 2020-09-30 | -623.70% |
| 2020-06-30 | -2552.25% |
| 2020-03-31 | -330.22% |
| 2019-12-31 | -748.89% |
| 2019-09-30 | -1750.58% |
| 2019-06-30 | -218.38% |
| 2019-03-31 | -78.78% |
| 2018-12-31 | -1056.38% |
| 2018-09-30 | -154.04% |
| 2018-06-30 | -224.89% |
| 2018-03-31 | -121396.54% |
| 2017-12-31 | -447.32% |
| 2017-09-30 | -674.06% |
| 2017-06-30 | -81232.58% |
| 2017-03-31 | -395.90% |
| 2016-12-31 | -492.46% |
| 2016-09-30 | -401.43% |
| 2016-06-30 | -24.05% |
| 2016-03-31 | -124.73% |
| 2015-12-31 | -74.26% |
| 2015-09-30 | -143.49% |
| 2015-06-30 | -170.92% |
| 2015-03-31 | 16.43% |
| 2014-12-31 | -143.65% |
| 2014-09-30 | -415.19% |
| 2014-06-30 | -31.97% |
| 2014-03-31 | -64.18% |
| 2013-12-31 | -138.69% |
| 2013-09-30 | -91.72% |
| 2013-06-30 | -34.50% |
| 2013-03-31 | -16.84% |
| 2012-12-31 | -23.73% |
| 2012-09-30 | -26.74% |
| 2012-06-30 | -23.08% |
| 2012-03-31 | -25.87% |
| 2011-12-31 | -17.35% |
| 2011-09-30 | -57.45% |
| 2011-06-30 | -47.93% |
| 2011-03-31 | -71.63% |
| 2010-12-31 | -105.71% |
| 2010-09-30 | -53.89% |
| 2010-06-30 | -115.85% |
| 2010-03-31 | -237.65% |
| 2009-12-31 | -84.79% |
| 2009-09-30 | -110.18% |
| 2009-06-30 | -83.88% |
| 2009-03-31 | -99.82% |
| 2008-12-31 | -87.05% |
| 2008-09-30 | -37.20% |
| 2008-06-30 | -197.81% |
| 2008-03-31 | -84.10% |
| 2007-12-31 | -89.31% |
| 2007-09-30 | -107.81% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 74.43% |
| 2006-12-31 | 54.63% |
| 2006-09-30 | 74.13% |
| 2006-06-30 | 72.50% |
| 2006-03-31 | 58.63% |
| 2005-12-31 | 45.11% |
| 2005-09-30 | 75.86% |
| 2005-06-30 | 0.00% |
